InMed stock jumped after preclinical data showed INM-901 lowered brain inflammation tied to Alzheimer's and improved ...

For adults with obesity or overweight without diabetes, the novel cyclic adenosine monophosphate-biased glucagon-like peptide ...

India's obesity drug market is set for intense competition with Novo Nordisk launching Wegovy to challenge Eli Lilly's Mounjaro, which gained early traction. Both drugs address rising obesity and ...

For adults with obesity or overweight without diabetes, the novel cyclic adenosine monophosphate-biased glucagon like peptide ...

This valuable manuscript investigates the localisation of nutrient receptors in bloodstream stage trypanosomes, with implications for both nutrient uptake and immune evasion. Results after direct ...

Onco360®, the nation’s leading independent specialty pharmacy, has been selected as a specialty pharmacy partner by Deciphera ...

DelveInsight's Sarcopenia Market Insights report includes a comprehensive understanding of current treatment practices, ...

GLP-1 drugs are revolutionizing the treatment of obesity and diabetes. Here's what to know about investing in GLP-1 stocks.

Hyperspectral imaging has provided an insight into how cells organize and prioritize organelle growth.

Your allergy pill might be working against your gym goals. A new study explains why histamine is essential for fitness gains.